Nuwellis, Inc. Common Stock (NUWE) Stock Price

NUWEStock

$0.89−99.51%52W

Market Cap$2.82M

P/E—

PEG Ratio—

Div yield—

Beta0.18

NUWE Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-110.35%

Price vs S&P 500 (4W)-46.33%

VGM Score40.20

Book Value / Share (Quarterly)$35.45

P/TBV (Annual)0.83x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-1.07%

Cash Flow / Share (Quarterly)$-154.00

Price vs S&P 500 (YTD)-111.36%

Gross Margin (TTM)65.47%

Net Profit Margin (TTM)-217.22%

EPS (TTM)$-170.52

10-Day Avg Trading Volume2.97M

EPS Excl Extra (TTM)$-170.52

Revenue Growth (5Y)2.14%

EPS (Annual)$-888.49

ROI (Annual)-666.20%

Gross Margin (Annual)61.96%

Net Profit Margin (5Y Avg)-196.92%

Cash / Share (Quarterly)$27.66

Revenue Growth QoQ (YoY)26.21%

ROA (Last FY)-286.38%

Revenue Growth TTM (YoY)-0.20%

EBITD / Share (TTM)$-148.58

ROE (5Y Avg)-331.89%

Operating Margin (TTM)-143.85%

Cash Flow / Share (Annual)$-226.24

P/B Ratio1.56x

P/B Ratio (Quarterly)1.04x

Net Income / Employee (Annual)$-461,100

EV / Revenue (TTM)0.24x

Net Interest Coverage (TTM)-0.66x

ROA (TTM)-251.77%

EPS Growth QoQ (YoY)-99.24%

EPS Incl Extra (Annual)$-888.49

Current Ratio (Annual)1.71x

Quick Ratio (Quarterly)1.09x

3-Month Avg Trading Volume2.40M

52-Week Price Return-99.51%

Revenue / Employee (TTM)$230,800

Tangible BV / Share (Quarterly)$33.96

P/S Ratio (Annual)0.50x

Asset Turnover (Annual)1.35x

52-Week High$183.75

Operating Margin (5Y Avg)-179.25%

EPS Excl Extra (Annual)$-888.49

CapEx CAGR (5Y)-21.40%

Tangible BV CAGR (5Y)-5.32%

26-Week Price Return-98.42%

Quick Ratio (Annual)1.08x

13-Week Price Return-97.01%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)1.56x

Enterprise Value$2.08M

Revenue / Share Growth (5Y)2.43%

Asset Turnover (TTM)1.16x

Book Value / Share Growth (5Y)-36.86%

Revenue / Employee (Annual)$217,600

Inventory Turnover (Annual)1.73x

Pretax Margin (Annual)-211.80%

Cash / Share (Annual)$22.52

3-Month Return Std Dev341.80%

Gross Margin (5Y Avg)59.11%

Net Income / Employee (TTM)$-501,300

ROE (Last FY)-666.20%

Net Interest Coverage (Annual)-0.19x

EPS Basic Excl Extra (Annual)$-888.49

Receivables Turnover (TTM)5.66x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-170.52

Receivables Turnover (Annual)5.14x

ROI (TTM)-211.49%

P/S Ratio (TTM)0.47x

Pretax Margin (5Y Avg)-196.85%

Revenue / Share (Annual)$419.37

Tangible BV / Share (Annual)$23.04

Price vs S&P 500 (52W)-118.07%

Year-to-Date Return-98.54%

5-Day Price Return-15.34%

EPS Normalized (Annual)$-888.49

ROA (5Y Avg)-145.92%

Net Profit Margin (Annual)-211.86%

Month-to-Date Return-48.91%

Cash Flow / Share (TTM)$-13.85

EBITD / Share (Annual)$-553.04

Operating Margin (Annual)-134.29%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-331.80%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-170.52

P/TBV (Quarterly)1.08x

P/B Ratio (Annual)1.10x

Inventory Turnover (TTM)1.72x

Pretax Margin (TTM)-217.17%

Book Value / Share (Annual)$54.59

Price vs S&P 500 (13W)-98.96%

Beta0.18x

Revenue / Share (TTM)$147.93

ROE (TTM)-211.49%

52-Week Low$0.86

vGradeA

gGradeD

mGradeF

vgmGradeC

NUWE Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q1 2026	May 12, 2026	-$35.00	-$73.15	-109.00%(-$38.15)
Q4 2025	Mar 10, 2026	-$54.60	-$52.50	+3.85%(+$2.10)
Q3 2025	Nov 12, 2025	—	$19.60	—
Q2 2025	Aug 14, 2025	—	-$2134.65	—

NUWE Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

2.17

Industry Peers — Electromedical Equipment(31)

Symbol	Value Score	Growth Score	Momentum Score	Price
NUWENuwellis, Inc. Common Stock	A	D	F	$0.89
MDTMedtronic plc	B	C	C	$91.23
LIVNLivaNova PLC Ordinary Shares	C	B	B	$80.32
ITGRInteger Holdings Corporation	C	C	B	$125.33
TMDXTransMedics Group, Inc. Common Stock	C	B	C	$88.43
AXGNAxogen, Inc. Common Stock	F	B	A	$51.47
BLFSBioLife Solutions Inc.	D	C	B	$36.38
CNMDCONMED Corporation	B	C	B	$49.98
CBLLCeriBell, Inc. Common Stock	D	A	B	$23.73
INMDInMode Ltd. Ordinary Shares	A	D	C	$14.85
CVCapsoVision, Inc. Common Stock	F	D	B	$5.93
ELMDElectromed, Inc.	D	B	C	$29.60
FOCLEDAP TMS S.A. American Depositary Shares	C	C	A	$4.31
STEXStreamex Corp. Common Stock	—	C	D	$0.77
STXSStereotaxis, Inc. Common Stock	D	D	D	$1.45
VANIVivani Medical, Inc. Common Stock (DE)	—	—	B	$1.42
HYPRHyperfine, Inc. Class A Common Stock	C	A	D	$0.83
ECORelectroCore, Inc. Common Stock	C	A	B	$9.63
NRXSNeuraxis, Inc.	F	B	B	$6.00
OMOutset Medical, Inc. Common Stock	A	C	D	$3.94
POCIPrecision Optics Corporation, Inc. Common Stock	C	A	C	$4.40
QTIQT Imaging Holdings, Inc. Common Stock	D	A	F	$3.09
IRIXIridex Corp	B	D	D	$0.71
ITOCiTonic Holdings Ltd Class A Ordinary Shares	—	A	C	$0.32
NDRAENDRA Life Sciences Inc. Common Stock	D	—	B	$5.00
NXLNexalin Technology, Inc. Common Stock	D	C	F	$0.25
EDAPEDAP TMS SA	C	B	B	$4.34
EYESCorgi Data & Surveillance ETF	—	C	B	$30.10
FONRFonar Corporation	B	D	B	$0.00
MASIMasimo Corporation	D	D	C	$0.00
QSIAWQuantum-Si Incorporated Warrant	—	—	F	$0.00
TIVCTivic Health Systems, Inc. Common Stock	—	B	F	$0.12

About Nuwellis, Inc. Common Stock

Nuwellis Inc manufactures ultrafiltration devices for treating fluid overload in patients unresponsive to conventional medical management. The company's primary products, the Aquadex FlexFlow and Aquadex SmartFlow systems, remove excess fluid in conditions such as congestive heart failure. Nuwellis operates a single business segment focused on fluid overload treatment.